Latest News
The study by Yale Cancer Center (YCC) researchers at Yale School of Medicine (YSM) discovered that not all CD8+ T cells are allies in a body’s fight against cancer cells. In a new study, patients living with severe melanoma who had increased levels of suppressor, regulatory CD8+ T cells had worse survival outcomes.
- January 24, 2024
Researchers say the new CAR-T cell therapy significantly reduced the number of cancerous T cells, while leaving healthy cells intact.
- March 07, 2023Source: Yale News
Yuval Kluger, who works in the broad fields of bioinformatics, machine learning, and applied mathematics to develop new approaches for analyzing large biological data sets, was recently appointed the Anthony N. Brady Professor of Pathology.
- March 07, 2023Source: YaleNews
Kluger works in the broad fields of bioinformatics, machine learning, and applied mathematics to develop approaches for analyzing large biological data sets.
- January 29, 2023
Aged bone marrow promotes the expansion of arterial smooth muscle cells and exacerbates the build-up of fatty deposits in artery walls, a new Yale study found.
- August 19, 2022
Chronic inflammation, one of the major hallmarks of aging, is thought to be partly caused by senescent cells that may accumulate in older individuals. Now, Yale researchers have received a grant from the National Institutes of Health (NIH) Common Fund’s Cellular Senescence Network Program (SenNet) to study these specialized cells.
- April 13, 2022
In a new study, Yale researchers take a unique approach to identify the molecular signals that induce a critical trigger for hair follicle formation and regeneration.
- December 16, 2021
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms? Researchers in the lab of Yale’s Richard Flavell decided to pose this question to a “humanized mice” and revealed that the causes of severe COVID may lie in our own antiviral inflammatory response to the virus, the researchers report Dec. 17 in the journal Nature Biotechnology, https://doi.org/10.1038/s41587-021-01155-4. “Early in the course of disease, a strong immune response is crucial for survival,” Sefik said. “Later in the disease, it can be fatal.” The humanized mice models might also reveal strong clues to the causes and potential treatments of so-called long and
... - July 30, 2020
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.